¼¼°èÀÇ ÀÏ·ºÆ®·ÎÄÄÇÇÅÏÆ® ¼¼Æ÷ ½ÃÀå : ¼¼Æ÷ À¯Çüº°, ÄÄÇÇÅÙÆ® À¯Çüº°, ¿ëµµº°, ÃÖÁ¾ »ç¿ëÀÚº°, ±¹°¡º°, Áö¿ªº° - »ê¾÷ ºÐ¼®, ½ÃÀå ±Ô¸ð, ½ÃÀå Á¡À¯À², ¿¹Ãø(2024-2032³â)
Electrocompetent Cells Market, By Cell Type, By Competency Type, By Application, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
»ùÇà ¿äû ¸ñ·Ï¿¡ Ãß°¡
º¸°í¼ ÇÏÀ̶óÀÌÆ®
ÀÏ·ºÆ®·ÎÄÄÇÇÅÏÆ® ¼¼Æ÷ ½ÃÀå ±Ô¸ð´Â 2023³â¿¡ 21¾ï 7,798¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2024³âºÎÅÍ 2032³â¿¡ °ÉÃÄ º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) 10.6%·Î È®´ëµÉ Àü¸ÁÀÔ´Ï´Ù.
ÀÏ·ºÆ®·ÎÄÄÇÇÅÏÆ® ¼¼Æ÷ ½ÃÀå : ½ÃÀå ¿ªÇÐ
À¯Àü¼º ÁúȯÀÇ À¯º´·üÀÌ Áõ°¡Çϸé ÀÏ·ºÆ®·ÎÄÄÇÇÅÏÆ® ¼¼Æ÷ ¼ö¿ä°¡ Áõ°¡
À¯Àü¼º ÁúȯÀÇ À¯º´·ü Áõ°¡´Â À¯ÀüÀÚ Å¬·Î´× ¹× À¯Àü °øÇп¡ ÇʼöÀûÀÎ ÀÏ·ºÆ®·ÎÄÄÇÇÅÏÆ® ¼¼Æ÷¿¡ ´ëÇÑ ¼ö¿ä¸¦ Å©°Ô Áõ°¡½Ã۰í ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, ¹Ì±¹ ±¹¸³À§»ý¿¬±¸¼Ò(NIH)´Â Áö³ 5³â°£ À¯ÀüÀÚ ÁúȯÀ» Æ÷ÇÔÇÑ ¿¬±¸ ÇÁ·ÎÁ§Æ®°¡ 30% Áõ°¡Çß´Ù°í º¸°íÇß½À´Ï´Ù. ¼¼°èº¸°Ç±â±¸(WHO)´Â À¯Àü¼º ÁúȯÀÌ Ãâ»ý¾ÆÀÇ ¾à 200¸í¿¡ 1¸íÀÇ ºñÀ²·Î ¹ßº´Çϰí ÀÖÀ½À» °Á¶Çϸç, °í±Þ ¿¬±¸ µµ±¸ÀÇ Çʿ伺À» Ã˱¸Çϰí ÀÖ½À´Ï´Ù. Bio-Rad Laboratories ¹× Thermo Fisher Scientific°ú °°Àº ±â¾÷Àº À¯ÀüÀÚ ¿¬±¸ ¹× Ä¡·á¿¡ ´ëÇÑ °ü½É Áõ°¡¿¡ ´ëÀÀÇÏ°í °í±Þ ÀüÀÚ ¿ª·® ¼¿À» Æ÷ÇÔÇÑ Æ÷Æ®Æú¸®¿À¸¦ È®´ëÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¼ö¿äÀÇ ±ÞÁõÀº À¯ÀüÀÚ ¿¬±¸¿Í ¸ÂÃãÇü ÀÇ·áÀÇ Áøº¸¸¦ °¡¼ÓÈÇϴµ¥ ÀÖ¾î¼ ÀÏ·ºÆ®·ÎÄÄÇÇÅÏÆ® ¼¿ÀÇ Áß¿äÇÑ ¿ªÇÒÀ» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù.
ÀÏ·ºÆ®·ÎÄÄÇÇÅÏÆ® ¼¼Æ÷ ½ÃÀå : ÁÖ¿ä ÀλçÀÌÆ®·Â
¿ì¸®ÀÇ ¸®¼Ä¡ ¾Ö³Î¸®½ºÆ®ÀÇ ºÐ¼®¿¡ µû¸£¸é ½ÃÀåÀº ¿¹Ãø ±â°£ µ¿¾È¿¡ ¾à 10.6%ÀÇ º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR)·Î ¸Å³â ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.
¼¼Æ÷ À¯Çü ¼¼ºÐÈ¿¡ ±Ù°ÅÇÏ¿©, ¹ÚÅ׸®¾Æ ¼¼Æ÷´Â 2023³â¿¡ ÃÖ´ë ½ÃÀå Á¡À¯À²À» º¸¿©ÁÙ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.
2023³â¿¡´Â À¯´ÉÇÑ À¯ÇüÀÇ ¼¼±×¸ÕÅ×À̼ÇÀ» ±â¹ÝÀ¸·Î ÀÏ·ºÆ®·ÎÄÄÇÇÅÏÆ® ¼¼Æ÷ÀÌ ÁÖ¿ä À¯ÇüÀ̾ú½À´Ï´Ù.
¿ëµµº°·Î´Â 2023³â¿¡´Â ´Ü¹éÁú ¹ßÇöÀÌ ÁÖ¿ä À¯ÇüÀ̾ú½À´Ï´Ù.
Áö¿ªº°·Î´Â ºÏ¹Ì°¡ 2023³â ¼öÀÍÀ¸·Î À̲ø¾ú½À´Ï´Ù.
ÀÏ·ºÆ®·ÎÄÄÇÇÅÏÆ® ¼¼Æ÷ ½ÃÀå : ¼¼ºÐÈ ºÐ¼® :
¼¼°è ÀÏ·ºÆ®·ÎÄÄÇÇÅÏÆ® ¼¼Æ÷ ½ÃÀåÀº ¼¿ À¯Çü, ÄÄÇÇÅÏÆ® À¯Çü, ¿ëµµ, ÃÖÁ¾ »ç¿ëÀÚ, Áö¿ª¿¡ µû¶ó ¼¼ºÐȵ˴ϴÙ.
½ÃÀåÀº ¼¼Æ÷ À¯Çü¿¡ µû¶ó ³× °¡Áö ¹üÁÖ·Î ³ª´¹´Ï´Ù. ¼¼±Õ ¼¼Æ÷, È¿¸ð ¼¼Æ÷, ½Ä¹° ¼¼Æ÷, Æ÷À¯·ù ¼¼Æ÷ÀÔ´Ï´Ù. ¹ÚÅ׸®¾Æ ¼¼Æ÷´Â À¯ÀüÀÚ ¿¬±¸¿¡ ³Î¸® »ç¿ëµÇ±â ¶§¹®¿¡ ¼ö¿ä°¡ ³ô°í, È¿¸ð ¼¼Æ÷´Â ±â´É ¿¬±¸¿¡ ÇʼöÀûÀÔ´Ï´Ù. Æ÷À¯·ù ¼¼Æ÷´Â °í±Þ ¿ëµµ¿¡ Áß¿äÇÏ¸ç ½Ä¹° ¼¼Æ÷´Â ´ú ÀαⰡ ÀÖ½À´Ï´Ù.
½ÃÀåÀº À¯´ÉÇÑ À¯Çü¿¡ µû¶ó µÎ °¡Áö ¹üÁÖ·Î ³ª´¹´Ï´Ù. ÀÏ·ºÆ®·ÎÄÄÇÇÅÏÆ® ¼¼Æ÷Àº ÇüÁúÀüȯ °úÁ¤¿¡¼ È¿À²¼º¿¡ ¿ì¼±ÀûÀ¸·Î »ç¿ëµÇ¸ç, ÈÇÐÀû ÄÄÇÇÅÏÆ® ¼¼Æ÷´Â ƯÁ¤ ¿ëµµ¿¡ »ç¿ëµË´Ï´Ù. ÀÏ·ºÆ®·ÎÄÄÇÇÅÏÆ® ¼¼Æ÷Àº ¹ü¿ë¼º°ú À¯ÀüÀÚ Á¶ÀÛ¿¡ ÀÖ¾î¼ÀÇ È¿´É¿¡ ÀÇÇØ º¸´Ù ³ôÀº ½ÃÀå Á¡À¯À²À» Â÷ÁöÇϰí ÀÖ½À´Ï´Ù.
ÀÏ·ºÆ®·ÎÄÄÇÇÅÏÆ® ¼¼Æ÷ ½ÃÀå : Áö¸®Àû ÀλçÀÌÆ®
ºÏ¹Ì´Â °ßÁ¶ÇÑ »ý¸í°øÇÐ ºÎ¹®°ú ´ë±Ô¸ð ¿¬±¸ ÅõÀÚ¸¦ ÅëÇØ ¼±µµÇϰí ÀÖ½À´Ï´Ù. ¹Ì±¹Àº ±¹¸³À§»ý¿¬±¸¼Ò(National Institutes of Health) µîÀÇ ±â°üÀÌ À¯Àü°øÇÐÀÇ ±¤¹üÀ§ÇÑ Á¶»ç¸¦ Áö¿øÇϰí ÀÖÀ¸¸ç, ÀÌ Áö¿ªÀÇ ¿ìÀ§¼º¿¡ °øÇåÇϰí ÀÖ½À´Ï´Ù. °·ÂÇÑ Á¦¾à»ê¾÷°ú »ý¸í°øÇлê¾÷ÀÌ °ßÀÎÇÏ´Â À¯·´ÀÌ ÀÌ¿¡ À̾îÁý´Ï´Ù. À¯·´¿¬ÇÕ(EU)ÀÇ 'È£¶óÀÌÁð, À¯·´' ÇÁ·Î±×·¥Àº À¯ÀüÀÚ¿¬±¸¿Í ¼¼Æ÷±â¼ú¿¡ °üÇÑ ¼ö¸¹Àº ÇÁ·ÎÁ§Æ®¿¡ ÀÚ±ÝÀ» Á¦°øÇØ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾ç, ƯÈ÷ Áß±¹°ú Àεµ´Â »ý¸í °øÇп¡¼ ¿¬±¸ Ȱµ¿°ú ÅõÀÚ°¡ Áõ°¡ÇÔ¿¡ µû¶ó ±Þ¼ÓÈ÷ »ó½ÂÇϰí ÀÖ½À´Ï´Ù. Áß±¹ÀÇ ±¹°¡Á¤Ã¥Àº À¯ÀüÀÚ¿¬±¸¿Í »ý¸í°øÇÐÀÇ ÁøÀüÀ» ÁöÁöÇϰí ÀÖÀ¸¸ç, ÇöÁö ´ëÇаú »ý¸í°øÇбâ¾÷°£¿¡ ¿©·¯ °øµ¿¿¬±¸°¡ ÁøÇàµÇ¾î ½ÃÀåÀÇ Á¸Àç°¨À» ³ôÀ̰í ÀÖ½À´Ï´Ù. ¶óƾ¾Æ¸Þ¸®Ä«¿¡¼´Â ºê¶óÁúÀÌ ¿¬±¸½Ã¼³ Áõ°¡¿Í ±¹Á¦ »ý¸í °øÇÐ ±â¾÷°úÀÇ Á¦È޷ΠȰ¾àÇϰí ÀÖ½À´Ï´Ù. °¢ Áö¿ªÀº Áö¿ªÀÇ ¿¬±¸ ÀÌ´Ï¼ÅÆ¼ºê¿Í Áö¿ø Á¤Ã¥¿¡ ÈûÀÔ¾î ´Ù¾çÇÑ °Á¡À¸·Î ½ÃÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.
ÀÏ·ºÆ®·ÎÄÄÇÇÅÏÆ® ¼¼Æ÷ ½ÃÀå : °æÀï ±¸µµ:
À¯·Â ±â¾÷ÀÎ Invitrogen CorporationÀº À¯Àü ¿¬±¸ ¾ÖÇø®ÄÉÀ̼ÇÀ» ÃßÁøÇϱâ À§ÇØ Ä¶¸®Æ÷´Ï¾Æ ´ëÇаúÀÇ Á¦ÈÞ µî Àü·«Àû Á¦ÈÞ¸¦ ÅëÇØ ±× ÁöÀ§¸¦ °ÈÇϰí ÀÖ½À´Ï´Ù. ¶Ç ´Ù¸¥ ÁÖ¿ä ±â¾÷ÀÎ Bio-Rad Laboratories´Â ÃÖ±Ù ¼±µµÀû ÀÎ »ý¸í °øÇÐ ±â¾÷ÀÇ ¼¼Æ÷ »ý¹°ÇÐ ºÎ¹®À» ÀμöÇÏ¿© Á¦Ç° Æ÷Æ®Æú¸®¿À¸¦ È®ÃæÇϰí ÀÏ·ºÆ®·ÎÄÄÇÇÅÏÆ® ¼¼Æ÷¿¡¼ Á¦Ç° Á¦°øÀ» °ÈÇϰí ÀÖ½À´Ï´Ù. ¾ÖÁú·±Æ® ±â¼úÀº À¯Àü°øÇÐÀ» Çõ½ÅÇϱâ À§ÇÑ ¿¬±¸ ÆÄÆ®³Ê½ÊÀ» Àû±ØÀûÀ¸·Î ¸Î°í ÀÖÀ¸¸ç, ±× ¾È¿¡´Â »õ·Î¿î ¾ÖÇø®ÄÉÀÌ¼Ç °³¹ßÀ» À§ÇÑ Á¦¾àȸ»ç ¿©·¯ ȸ»ç¿ÍÀÇ °øµ¿ ¿¬±¸µµ Æ÷ÇԵǾî ÀÖ½À´Ï´Ù. ´ºÀ×±Û·£µå ¹ÙÀÌ¿À·¦½º´Â ¶ÇÇÑ ´Ù¾çÇÑ ÀÏ·ºÆ®·ÎÄÄÇÇÅÏÆ® ¼¼Æ÷ÀÇ ±¸»ö°ú À¯ÀüÀÚ ¿¬±¸¸¦ ÃßÁøÇϱâ À§ÇÑ ¼¼°èÀû ¿¬±¸±â°ü°úÀÇ Á¦ÈÞ·Î ¾Ë·ÁÁø Áß¿äÇÑ ±â¾÷ÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ±â¾÷µéÀº Àμö, Á¦ÈÞ, Àü·«Àû ÆÄÆ®³Ê½ÊÀ» Ȱ¿ëÇÏ¿© ±â¼ú Çõ½Å°ú ½ÃÀå¿¡¼ÀÇ Á¸Àç°¨À» È®´ëÇϰí ÀÖÀ¸¸ç, ÀÏ·ºÆ®·ÎÄÄÇÇÅÏÆ® ¼¼Æ÷ ½ÃÀå ÀüüÀÇ ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.
¸ñÂ÷
Á¦1Àå ÀÏ·ºÆ®·ÎÄÄÇÇÅÏÆ® ¼¼Æ÷ ½ÃÀå °³¿ä
Á¦2Àå ÁÖ¿ä ¿ä¾à
Á¦3Àå ÀÏ·ºÆ®·ÎÄÄÇÇÅÏÆ® ¼¼Æ÷ÀÇ ÁÖ¿ä ½ÃÀå µ¿Çâ
½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
½ÃÀå ±âȸ
½ÃÀåÀÇ ¹Ì·¡ µ¿Çâ
Á¦4Àå ÀÏ·ºÆ®·ÎÄÄÇÇÅÏÆ® ¼¼Æ÷ »ê¾÷ÀÇ Á¶»ç
PEST ºÐ¼®
Porter's Five Forces ºÐ¼®
¼ºÀå Àü¸Á ¸ÊÇÎ
±ÔÁ¦ Ʋ ºÐ¼®
Á¦5Àå ÀÏ·ºÆ®·ÎÄÄÇÇÅÏÆ® ¼¼Æ÷ ½ÃÀå : COVID-19ÀÇ ¿µÇ⠺м®
COVID-19 ÀÌÀüÀÇ ¿µÇ⠺м®
COVID-19 ÀÌÈÄÀÇ ¿µÇ⠺м®
Á¦6Àå ÀÏ·ºÆ®·ÎÄÄÇÇÅÏÆ® ¼¼Æ÷ ½ÃÀå »óȲ
ÀÏ·ºÆ®·ÎÄÄÇÇÅÏÆ® ¼¼Æ÷ ½ÃÀå Á¡À¯À² ºÐ¼®(2023³â)
ÁÖ¿ä Á¦Á¶¾÷üº° ºÐ¼® µ¥ÀÌÅÍ
±âÁ¸ ±â¾÷ÀÇ ºÐ¼®
½ÅÈï±â¾÷ÀÇ ºÐ¼®
Á¦7Àå ÀÏ·ºÆ®·ÎÄÄÇÇÅÏÆ® ¼¼Æ÷ ½ÃÀå : ¼¼Æ÷ À¯Çüº°
°³¿ä
ºÎ¹® Á¡À¯À² ºÐ¼®
¼¼±Õ ¼¼Æ÷
È¿¸ð ¼¼Æ÷
½Ä¹° ¼¼Æ÷
Æ÷À¯·ù ¼¼Æ÷
Á¦8Àå ÀÏ·ºÆ®·ÎÄÄÇÇÅÏÆ® ¼¼Æ÷ ½ÃÀå : ÄÄÇÇÅϽà À¯Çüº°
°³¿ä
ºÎ¹® Á¡À¯À² ºÐ¼®
ÈÇÐÀûÀ¸·Î À¯´ÉÇÑ ¼¼Æ÷
ÀÏ·ºÆ®·ÎÄÄÇÇÅÏÆ® ¼¼Æ÷
Á¦9Àå ÀÏ·ºÆ®·ÎÄÄÇÇÅÏÆ® ¼¼Æ÷ ½ÃÀå : ¿ëµµº°
°³¿ä
ºÎ¹® Á¡À¯À² ºÐ¼®
Ŭ·Ð
´Ü¹éÁú ¹ßÇö
¹ÙÀÌ·¯½º »ý»ê
±âŸ
Á¦10Àå ÀÏ·ºÆ®·ÎÄÄÇÇÅÏÆ® ¼¼Æ÷ ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°
°³¿ä
ÃÖÁ¾ »ç¿ëÀÚº° ºÎ¹® Á¡À¯À² ºÐ¼®
¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ±â¾÷
Á¦¾àȸ»ç
Çмú¿¬±¸±â°ü
°è¾à¿¬±¸±â°ü(CRO)
Á¦11Àå ÀÏ·ºÆ®·ÎÄÄÇÇÅÏÆ® ¼¼Æ÷ ½ÃÀå : Áö¿ªº°
¼Ò°³
ºÏ¹Ì
°³¿ä
ºÏ¹ÌÀÇ ÁÖ¿ä Á¦Á¶¾÷ü
¹Ì±¹
ij³ª´Ù
À¯·´
°³¿ä
À¯·´ÀÇ ÁÖ¿ä Á¦Á¶¾÷ü
µ¶ÀÏ
ÀÌÅ»¸®¾Æ
¿µ±¹
ÇÁ¶û½º
·¯½Ã¾Æ
³×´ú¶õµå
½º¿þµ§
Æú¶õµå
±âŸ
¾Æ½Ã¾ÆÅÂÆò¾ç(APAC)
°³¿ä
¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÁÖ¿ä Á¦Á¶¾÷ü
Àεµ
Áß±¹
ÀϺ»
Çѱ¹
È£ÁÖ
ű¹
Àεµ³×½Ã¾Æ
Çʸ®ÇÉ
±âŸ
¶óƾ¾Æ¸Þ¸®Ä«
°³¿ä
¶óƾ¾Æ¸Þ¸®Ä«ÀÇ ÁÖ¿ä Á¦Á¶¾÷ü
ºê¶óÁú
¸ß½ÃÄÚ
¾Æ¸£ÇîÆ¼³ª
ÄÝ·Òºñ¾Æ
±âŸ
Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
°³¿ä
Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ÁÖ¿ä Á¦Á¶¾÷ü
»ç¿ìµð¾Æ¶óºñ¾Æ
¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
À̽º¶ó¿¤
ÅÍŰ
¾ËÁ¦¸®
ÀÌÁýÆ®
±âŸ
Á¦12Àå ÁÖ¿ä º¥´õ ºÐ¼® - ÀÏ·ºÆ®·ÎÄÄÇÇÅÏÆ® ¼¼Æ÷ ¾÷°è
°æÀï ´ë½Ãº¸µå
±â¾÷ ÇÁ·ÎÆÄÀÏ
Agilent Technologies, Inc.
Bioline(Meridian Bioscience, Inc.)
Bio-Rad Laboratories, Inc.
Cell Applications, Inc.
Edge BioSystems
GenScript Biotech Corporation
IBA Lifesciences GmbH
Lucigen Corporation
Merck KGaA
New England Biolabs, Inc.
Promega Corporation
QIAGEN NV
Takara Bio Inc.
Thermo Fisher Scientific Inc.
TransGen Biotech Co., Ltd.
Zymo Research Corporation
Others
Á¦13Àå ¾Ö³Î¸®½ºÆ®ÀÇ Àü¹æÀ§ Àü¸Á
BJH
REPORT HIGHLIGHT
Electrocompetent Cells Market size was valued at USD 2,177.98 Million in 2023, expanding at a CAGR of 10.6% from 2024 to 2032.
The Electrocompetent Cells Market focuses on cells capable of taking up foreign DNA through electrotransformation, essential for genetic engineering and biotechnology applications. Growth in this market is spurred by the rising demand for advanced research tools and biopharmaceutical production, with applications ranging from gene therapy to synthetic biology. For instance, the increasing prevalence of genetic disorders has led to a surge in gene editing research, pushing the demand for high-quality electrocompetent cells. However, challenges such as the high cost of cell preparation and the complexity of the electrotransformation process can impede market growth. Opportunities lie in the development of more cost-effective and efficient electrocompetent cells, driven by advancements in biotechnology and increased research funding. Additionally, the expansion of genomic research and the growing focus on personalized medicine further boost the need for these cells, exemplified by recent collaborations between biotech firms and research institutions aimed at enhancing genetic modification techniques.
Electrocompetent Cells Market- Market Dynamics
Increasing Prevalence of Genetic Disorders Boosts Demand for Electrocompetent Cells
The rising prevalence of genetic disorders is significantly increasing the demand for electrocompetent cells, essential for gene cloning and genetic engineering. For instance, the National Institutes of Health (NIH) reported a 30% increase in research projects involving genetic disorders over the past five years. The World Health Organization (WHO) highlighted that genetic disorders affect approximately 1 in 200 live births, driving the need for advanced research tools. Companies like Bio-Rad Laboratories and Thermo Fisher Scientific have expanded their portfolios to include advanced electrocompetent cells, responding to the growing focus on genetic research and therapy. This surge in demand underscores the critical role of electrocompetent cells in accelerating advancements in genetic research and personalized medicine.
Electrocompetent Cells Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 10.6% over the forecast period (2024-2032)
Based on Cell Type segmentation, Bacterial Cells were predicted to show maximum market share in the year 2023
Based on Competency Type segmentation, Electrocompetent Cells were the leading type in 2023
Based on Application segmentation, Protein Expression was the leading type in 2023
Based on region, North America was the leading revenue generator in 2023
Electrocompetent Cells Market- Segmentation Analysis:
The Global Electrocompetent Cells Market is segmented based on Cell Type, Competency Type, Application, End-User, and Region.
The market is divided into four categories based on Cell Type: Bacterial Cells, Yeast Cells, Plant Cells, and Mammalian Cells. Bacterial cells lead in demand due to their widespread use in genetic research, followed by yeast cells, which are crucial for functional studies. Mammalian cells are important for advanced applications, while plant cells are less prevalent.
The market is divided into two categories based on Competency Type: Chemically Competent Cells and Electrocompetent Cells. Electrocompetent cells are prioritized due to their efficiency in transformation processes, while chemically competent cells are used in specific applications. Electrocompetent cells hold a higher market share due to their versatility and effectiveness in gene manipulation.
Electrocompetent Cells Market- Geographical Insights
North America leads due to its robust biotechnology sector and significant research investments. The U.S., with institutions like the National Institutes of Health, supports extensive research in genetic engineering, contributing to the region's dominance. Europe follows, driven by its strong pharmaceutical and biotech industries. The European Union's Horizon Europe program funds numerous projects in genetic research and cell technology, boosting market growth. Asia-Pacific, notably China and India, is emerging rapidly due to increasing research activities and investments in biotechnology. China's national policies favor advancements in genetic research and biotechnology, with several collaborations between local universities and biotech firms enhancing market presence. In Latin America, Brazil is making strides with increasing research facilities and collaborations with international biotech companies. Each region is contributing to the global market with varied strengths, driven by regional research initiatives and supportive policies.
Electrocompetent Cells Market- Competitive Landscape:
Invitrogen Corporation, a prominent player, has strengthened its position through strategic collaborations, including a partnership with the University of California for advancing genetic research applications. Bio-Rad Laboratories, another leading company, recently expanded its product portfolio by acquiring the cell biology division of a major biotech firm, enhancing its offerings in electrocompetent cells. Agilent Technologies has been active in forming research partnerships to innovate in genetic engineering, including collaborations with several pharmaceutical companies to develop new applications. New England Biolabs is also a significant player, known for its extensive range of electrocompetent cells and its partnership with global research institutions to advance genetic research. These companies are leveraging acquisitions, collaborations, and strategic partnerships to innovate and expand their market presence, contributing to the overall growth of the Electrocompetent Cells Market.
Recent Developments:
In April 2022, Thermo Fisher Scientific introduced the Gibco CTS Xenon Electroporation System, designed for large-scale cell therapy development. This system enhances gene modification efficiency and allows a seamless transition from clinical to commercial manufacturing, achieving high cell viability and transfection rates.
In January 2020, SGI-DNA launched Vmax(TM) X2 Competent Cells, derived from the marine bacterium Vibrio natriegens. These cells grow twice as fast as E. coli, yielding two to four times more soluble protein, significantly enhancing protein expression efficiency and flexibility for researchers.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL ELECTROCOMPETENT CELLS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
Agilent Technologies, Inc.
Bioline (Meridian Bioscience, Inc.)
Bio-Rad Laboratories, Inc.
Cell Applications, Inc.
Edge BioSystems
GenScript Biotech Corporation
IBA Lifesciences GmbH
Lucigen Corporation
Merck KGaA
New England Biolabs, Inc.
Promega Corporation
QIAGEN N.V.
Takara Bio Inc.
Thermo Fisher Scientific Inc.
TransGen Biotech Co., Ltd.
Zymo Research Corporation
Others
GLOBAL ELECTROCOMPETENT CELLS MARKET, BY CELL TYPE- MARKET ANALYSIS, 2019 - 2032
Bacterial Cells
Yeast Cells
Plant Cells
Mammalian Cells
GLOBAL ELECTROCOMPETENT CELLS MARKET, BY COMPETENCY TYPE- MARKET ANALYSIS, 2019 - 2032
Chemically Competent Cells
Electrocompetent Cells
GLOBAL ELECTROCOMPETENT CELLS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032
Cloning
Protein Expression
Virus Production
Other
GLOBAL ELECTROCOMPETENT CELLS MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032
Biotechnology Companies
Pharmaceutical Companies
Academic & Research Institutes
Contract Research Organizations (CROs)
GLOBAL ELECTROCOMPETENT CELLS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA
Table of Contents
1. Electrocompetent Cells Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Electrocompetent Cells Market Snippet by Cell Type
2.1.2. Electrocompetent Cells Market Snippet by Competency Type
2.1.3. Electrocompetent Cells Market Snippet by Application
2.1.4. Electrocompetent Cells Market Snippet by End-User
2.1.5. Electrocompetent Cells Market Snippet by Country
2.1.6. Electrocompetent Cells Market Snippet by Region
2.2. Competitive Insights
3. Electrocompetent Cells Key Market Trends
3.1. Electrocompetent Cells Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Electrocompetent Cells Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Electrocompetent Cells Market Opportunities
3.4. Electrocompetent Cells Market Future Trends
4. Electrocompetent Cells Industry Study
4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Electrocompetent Cells Market: COVID-19 Impact Analysis
5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
5.2.1. Top Performing Segments
5.2.2. Marginal Growth Segments
5.2.3. Top Looser Segments
5.2.4. Marginal Loss Segments
6. Electrocompetent Cells Market Landscape
6.1. Electrocompetent Cells Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players' Analysis
6.2.2. Emerging Players' Analysis
7. Electrocompetent Cells Market - By Cell Type
7.1. Overview
7.1.1. Segment Share Analysis, By Cell Type, 2023 & 2032 (%)
7.1.2. Bacterial Cells
7.1.3. Yeast Cells
7.1.4. Plant Cells
7.1.5. Mammalian Cells
8. Electrocompetent Cells Market - By Competency Type
8.1. Overview
8.1.1. Segment Share Analysis, By Competency Type, 2023 & 2032 (%)
8.1.2. Chemically Competent Cells
8.1.3. Electrocompetent Cells
9. Electrocompetent Cells Market - By Application
9.1. Overview
9.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
9.1.2. Cloning
9.1.3. Protein Expression
9.1.4. Virus Production
9.1.5. Other
10. Electrocompetent Cells Market - By End-User
10.1. Overview
10.1.1. Segment Share Analysis, By End-User, 2023 & 2032 (%)
10.1.2. Biotechnology Companies
10.1.3. Pharmaceutical Companies
10.1.4. Academic & Research Institutes
10.1.5. Contract Research Organizations (CROs)
11. Electrocompetent Cells Market- By Geography
11.1. Introduction
11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
11.2. North America
11.2.1. Overview
11.2.2. Electrocompetent Cells Key Manufacturers in North America
11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.2.4. North America Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
11.2.5. North America Market Size and Forecast, By Competency Type, 2019 - 2032 (US$ Million)
11.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.2.7. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.2.8. U.S.
11.2.8.1. Overview
11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.2.8.3. U.S. Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
11.2.8.4. U.S. Market Size and Forecast, By Competency Type, 2019 - 2032 (US$ Million)
11.2.8.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.2.8.6. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.2.9. Canada
11.2.9.1. Overview
11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.2.9.3. Canada Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
11.2.9.4. Canada Market Size and Forecast, By Competency Type, 2019 - 2032 (US$ Million)
11.2.9.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.2.9.6. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.3. Europe
11.3.1. Overview
11.3.2. Electrocompetent Cells Key Manufacturers in Europe
11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.3.4. Europe Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
11.3.5. Europe Market Size and Forecast, By Competency Type, 2019 - 2032 (US$ Million)
11.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.7. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.3.8. Germany
11.3.8.1. Overview
11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.8.3. Germany Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
11.3.8.4. Germany Market Size and Forecast, By Competency Type, 2019 - 2032 (US$ Million)
11.3.8.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.8.6. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.3.9. Italy
11.3.9.1. Overview
11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.9.3. Italy Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
11.3.9.4. Italy Market Size and Forecast, By Competency Type, 2019 - 2032 (US$ Million)
11.3.9.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.9.6. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.3.10. United Kingdom
11.3.10.1. Overview
11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.10.3. United Kingdom Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
11.3.10.4. United Kingdom Market Size and Forecast, By Competency Type, 2019 - 2032 (US$ Million)
11.3.10.5. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.10.6. United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.3.11. France
11.3.11.1. Overview
11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.11.3. France Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
11.3.11.4. France Market Size and Forecast, By Competency Type, 2019 - 2032 (US$ Million)
11.3.11.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.11.6. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.3.12. Russia
11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.12.2. Russia Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
11.3.12.3. Russia Market Size and Forecast, By Competency Type, 2019 - 2032 (US$ Million)
11.3.12.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.12.5. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.3.13. Netherlands
11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.13.2. Netherlands Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
11.3.13.3. Netherlands Market Size and Forecast, By Competency Type, 2019 - 2032 (US$ Million)
11.3.13.4. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.13.5. Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.3.14. Sweden
11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.14.2. Sweden Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
11.3.14.3. Sweden Market Size and Forecast, By Competency Type, 2019 - 2032 (US$ Million)
11.3.14.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.14.5. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.3.15. Poland
11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.15.2. Poland Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
11.3.15.3. Poland Market Size and Forecast, By Competency Type, 2019 - 2032 (US$ Million)
11.3.15.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.15.5. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.3.16. Rest of Europe
11.3.16.1. Overview
11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.16.3. Rest of the Europe Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
11.3.16.4. Rest of the Europe Market Size and Forecast, By Competency Type, 2019 - 2032 (US$ Million)
11.3.16.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.16.6. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.4. Asia Pacific (APAC)
11.4.1. Overview
11.4.2. Electrocompetent Cells Key Manufacturers in Asia Pacific
11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.4.4. Asia Pacific Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
11.4.5. Asia Pacific Market Size and Forecast, By Competency Type, 2019 - 2032 (US$ Million)
11.4.6. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.7. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.4.8. India
11.4.8.1. Overview
11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.8.3. India Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
11.4.8.4. India Market Size and Forecast, By Competency Type, 2019 - 2032 (US$ Million)
11.4.8.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.8.6. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.4.9. China
11.4.9.1. Overview
11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.9.3. China Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
11.4.9.4. China Market Size and Forecast, By Competency Type, 2019 - 2032 (US$ Million)
11.4.9.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.9.6. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.4.10. Japan
11.4.10.1. Overview
11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.10.3. Japan Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
11.4.10.4. Japan Market Size and Forecast, By Competency Type, 2019 - 2032 (US$ Million)
11.4.10.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.10.6. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.4.11. South Korea
11.4.11.1. Overview
11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.11.3. South Korea Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
11.4.11.4. South Korea Market Size and Forecast, By Competency Type, 2019 - 2032 (US$ Million)
11.4.11.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.11.6. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.4.12. Australia
11.4.12.1. Overview
11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.12.3. Australia Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
11.4.12.4. Australia Market Size and Forecast, By Competency Type, 2019 - 2032 (US$ Million)
11.4.12.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.12.6. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.4.13. Thailand
11.4.13.1. Overview
11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.13.3. Thailand Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
11.4.13.4. Thailand Market Size and Forecast, By Competency Type, 2019 - 2032 (US$ Million)
11.4.13.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.13.6. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.4.14. Indonesia
11.4.14.1. Overview
11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.14.3. Indonesia Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
11.4.14.4. Indonesia Market Size and Forecast, By Competency Type, 2019 - 2032 (US$ Million)
11.4.14.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.14.6. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.4.15. Philippines
11.4.15.1. Overview
11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.15.3. Philippines Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
11.4.15.4. Philippines Market Size and Forecast, By Competency Type, 2019 - 2032 (US$ Million)
11.4.15.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.15.6. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.4.16. Rest of APAC
11.4.16.1. Overview
11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.16.3. Rest of APAC Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
11.4.16.4. Rest of APAC Market Size and Forecast, By Competency Type, 2019 - 2032 (US$ Million)
11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.16.6. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.5. Latin America
11.5.1. Overview
11.5.2. Electrocompetent Cells Key Manufacturers in Latin America
11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.5.4. Latin America Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
11.5.5. Latin America Market Size and Forecast, By Competency Type, 2019 - 2032 (US$ Million)
11.5.6. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.7. Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.5.8. Brazil
11.5.8.1. Overview
11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.8.3. Brazil Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
11.5.8.4. Brazil Market Size and Forecast, By Competency Type, 2019 - 2032 (US$ Million)
11.5.8.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.8.6. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.5.9. Mexico
11.5.9.1. Overview
11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.9.3. Mexico Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
11.5.9.4. Mexico Market Size and Forecast, By Competency Type, 2019 - 2032 (US$ Million)
11.5.9.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.9.6. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.5.10. Argentina
11.5.10.1. Overview
11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.10.3. Argentina Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
11.5.10.4. Argentina Market Size and Forecast, By Competency Type, 2019 - 2032 (US$ Million)
11.5.10.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.10.6. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.5.11. Colombia
11.5.11.1. Overview
11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.11.3. Colombia Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
11.5.11.4. Colombia Market Size and Forecast, By Competency Type, 2019 - 2032 (US$ Million)
11.5.11.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.11.6. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.5.12. Rest of LATAM
11.5.12.1. Overview
11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.12.3. Rest of LATAM Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
11.5.12.4. Rest of LATAM Market Size and Forecast, By Competency Type, 2019 - 2032 (US$ Million)
11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.12.6. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.6. Middle East and Africa
11.6.1. Overview
11.6.2. Electrocompetent Cells Key Manufacturers in Middle East and Africa
11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.6.4. Middle East and Africa Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
11.6.5. Middle East and Africa Market Size and Forecast, By Competency Type, 2019 - 2032 (US$ Million)
11.6.6. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.7. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.6.8. Saudi Arabia
11.6.8.1. Overview
11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.8.3. Saudi Arabia Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
11.6.8.4. Saudi Arabia Market Size and Forecast, By Competency Type, 2019 - 2032 (US$ Million)
11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.8.6. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.6.9. United Arab Emirates
11.6.9.1. Overview
11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.9.3. United Arab Emirates Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
11.6.9.4. United Arab Emirates Market Size and Forecast, By Competency Type, 2019 - 2032 (US$ Million)
11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.9.6. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.6.10. Israel
11.6.10.1. Overview
11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.10.3. Israel Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
11.6.10.4. Israel Market Size and Forecast, By Competency Type, 2019 - 2032 (US$ Million)
11.6.10.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.10.6. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.6.11. Turkey
11.6.11.1. Overview
11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.11.3. Turkey Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
11.6.11.4. Turkey Market Size and Forecast, By Competency Type, 2019 - 2032 (US$ Million)
11.6.11.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.11.6. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.6.12. Algeria
11.6.12.1. Overview
11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.12.3. Algeria Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
11.6.12.4. Algeria Market Size and Forecast, By Competency Type, 2019 - 2032 (US$ Million)
11.6.12.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.12.6. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.6.13. Egypt
11.6.13.1. Overview
11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.13.3. Egypt Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
11.6.13.4. Egypt Market Size and Forecast, By Competency Type, 2019 - 2032 (US$ Million)
11.6.13.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.13.6. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.6.14. Rest of MEA
11.6.14.1. Overview
11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.14.3. Rest of MEA Market Size and Forecast, By Cell Type, 2019 - 2032 (US$ Million)
11.6.14.4. Rest of MEA Market Size and Forecast, By Competency Type, 2019 - 2032 (US$ Million)
11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.14.6. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
12. Key Vendor Analysis- Electrocompetent Cells Industry
12.1. Competitive Dashboard
12.2. Company Profiles
12.2.1. Agilent Technologies, Inc.
12.2.2. Bioline (Meridian Bioscience, Inc.)
12.2.3. Bio-Rad Laboratories, Inc.
12.2.4. Cell Applications, Inc.
12.2.5. Edge BioSystems
12.2.6. GenScript Biotech Corporation
12.2.7. IBA Lifesciences GmbH
12.2.8. Lucigen Corporation
12.2.9. Merck KGaA
12.2.10. New England Biolabs, Inc.
12.2.11. Promega Corporation
12.2.12. QIAGEN N.V.
12.2.13. Takara Bio Inc.
12.2.14. Thermo Fisher Scientific Inc.
12.2.15. TransGen Biotech Co., Ltd.
12.2.16. Zymo Research Corporation
12.2.17. Others
13. 360 Degree Analyst View
14. Appendix
14.1. Research Methodology
14.2. References
14.3. Abbreviations
14.4. Disclaimer
14.5. Contact Us